Hologic Recall Triggers US Shortage of Breast Biopsy Needles, FDA Says
Hologic Recall Triggers US Shortage of Breast Biopsy Needles, FDA Says
CoinLive
The US Food and Drug Administration said the US is experiencing a shortage of breast biopsy needles after Hologic Inc. recalled the products earlier this year. According to Bloomberg, the shortage could delay breast cancer diagnoses for some patients.
